Premium
Swiss investment firm HBM Healthcare has led a Rs 801 crore ($95 million) funding round in an Indian contract drug manufacturing company that also counts private equity firm TPG as an investor. HBM and other investors including WhiteOak Capital, Param Capital, Motilal Oswal, Enam Holdings and SBI Life Insurance Co Ltd ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
